Part 6/9:
U.S. pharmaceutical lobbyists have pushed Trump to threaten tariffs as retaliation against Australia's PBS policies. The American industry’s stance has created a diplomatic headache, forcing domestic leaders to consider their next move carefully. Critics argue that Australia’s pharmaceutical exports, worth over $2 billion annually, could be jeopardized if tariffs are implemented or if negotiations do not favor Australian interests.